vidarabine has been researched along with Paraproteinemias in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hogan, JJ; Weiss, BM | 1 |
| Eurelings, M; Franssen, H; Lokhorst, HL; Niermeijer, JM; Notermans, NC; van der Pol, WL; Wokke, JH | 1 |
| Beaumont, M; Garidi, R; Ghomari, K; Gruson, B; Just, A; Marolleau, JP; Merle, P; Merlusca, L; Royer, B | 1 |
| Bergier, G; Glass, F; McCardle, T; Moscinski, L; Naghashpour, M; Setoodeh, R; Sokol, L | 1 |
| Eurelings, M; Fijnheer, R; Franssen, H; Lokhorst, H; Niermeijer, JM; Notermans, NC; Wokke, JH | 1 |
| Hughes, RA; Lunn, MP; Schey, S; Wilson, HC | 1 |
| del Potro Gómez, E; Morales Sanz, D | 1 |
| Dwyer, KM; Firkin, F; Hill, PA; Lee, P; Murphy, BF | 1 |
2 review(s) available for vidarabine and Paraproteinemias
| Article | Year |
|---|---|
Bridging the Divide: An Onco-Nephrologic Approach to the Monoclonal Gammopathies of Renal Significance.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bortezomib; Cyclophosphamide; Dexamethasone; Humans; Immunoglobulins; Immunosuppressive Agents; Kidney Diseases; Lenalidomide; Melphalan; Oligopeptides; Paraproteinemias; Pentostatin; Rituximab; Thalidomide; Vidarabine | 2016 |
[Multiple myeloma and other plasma cell dyscrasias].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Child; Diagnosis, Differential; Heavy Chain Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Melphalan; Multiple Myeloma; Paraproteinemias; Prednisone; Prognosis; Time Factors; Vidarabine; Waldenstrom Macroglobulinemia | 1999 |
2 trial(s) available for vidarabine and Paraproteinemias
| Article | Year |
|---|---|
Rituximab for polyneuropathy with IgM monoclonal gammopathy.
Topics: Age of Onset; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; B-Lymphocytes; Bone Marrow Cells; Cyclophosphamide; Disability Evaluation; Female; Humans; Immunoglobulin M; Immunologic Factors; Immunosuppressive Agents; Lymphocyte Count; Male; Middle Aged; Muscle Strength; Neural Conduction; Paraproteinemias; Prednisone; Prospective Studies; Rituximab; Sensation; Treatment Outcome; Vidarabine | 2009 |
Neurologic and hematologic response to fludarabine treatment in IgM MGUS polyneuropathy.
Topics: Aged; Aged, 80 and over; Female; Follow-Up Studies; Humans; Immunoglobulin M; Male; Middle Aged; Paraproteinemias; Polyneuropathies; Prospective Studies; Vidarabine | 2006 |
4 other study(ies) available for vidarabine and Paraproteinemias
| Article | Year |
|---|---|
Long-term response to rituximab and fludarabine combination in IgM anti-myelin-associated glycoprotein neuropathy.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Autoantigens; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunoglobulin M; Immunologic Factors; Male; Middle Aged; Myelin-Associated Glycoprotein; Paraproteinemias; Polyradiculoneuropathy; Rituximab; Vidarabine | 2011 |
Nonnecrobiotic necrobiotic xanthogranuloma as an initial manifestation of paraproteinemia and small lymphocytic lymphoma in a patient with Sjögren syndrome.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Biopsy; Cyclophosphamide; Drug Therapy, Combination; Eyelids; Female; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Necrobiotic Xanthogranuloma; Paraproteinemias; Rituximab; Sjogren's Syndrome; Treatment Outcome; Vidarabine | 2011 |
Successful treatment of IgM paraproteinaemic neuropathy with fludarabine.
Topics: Aged; Aged, 80 and over; Female; Humans; Immunoglobulin M; Immunosuppressive Agents; Male; Middle Aged; Paraproteinemias; Peripheral Nervous System Diseases; Vidarabine | 1999 |
Membranoproliferative glomerulonephritis in association with chronic lymphocytic leukaemia: a report of three cases.
Topics: Adult; Aged; Antineoplastic Agents; Chlorambucil; Drug Therapy, Combination; Female; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Humans; Kidney Glomerulus; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Microscopy, Fluorescence; Middle Aged; Paraproteinemias; Prednisolone; Treatment Outcome; Vidarabine | 2002 |